SALMONELLA-TYPHI VACCINE STRAIN CVD-908 EXPRESSING THE CIRCUMSPOROZOITE PROTEIN OF PLASMODIUM-FALCIPARUM - STRAIN CONSTRUCTION AND SAFETY AND IMMUNOGENICITY IN HUMANS

被引:99
|
作者
GONZALEZ, C
HONE, D
NORIEGA, FR
TACKET, CO
DAVIS, JR
LOSONSKY, G
NATARO, JP
HOFFMAN, S
MALIK, A
NARDIN, E
SZTEIN, MB
HEPPNER, DG
FOUTS, TR
ISIBASI, A
LEVINE, MM
机构
[1] UNIV MARYLAND, SCH MED, CTR VACCINE DEV, BALTIMORE, MD 21201 USA
[2] NATL NAVAL MED CTR, BETHESDA, MD 20814 USA
[3] INST MEXICANO SEGURO SOCIAL, UNIDAD INVEST MED & IMMUNOQUIM, MEXICO CITY, DF, MEXICO
[4] NYU, SCH MED, DEPT MED & MOLEC PARASITOL, NEW YORK, NY USA
关键词
D O I
10.1093/infdis/169.4.927
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
rcsp, encoding amino acids 21-398 of Plasmodium falciparum circumsporozoite protein (CSP), under control of P-tac was integrated into the chromosomal Delta aroC locus of attenuated Delta aroC, Delta aroD Salmonella typhi CVD 908. By immunoblot and ELISA, rCSP expression was greater from a multicopy plasmid than from the single chromosomal gene. CVD 908 Omega(Delta aroC1019::P-tac-rcsp) was well tolerated by 10 volunteers who were fed two doses of 5 x 10(7) organisms 8 days apart. Seven subjects excreted the vaccine strain for 1-3 days. All subjects developed serologic responses to O and H antigens of the live vector, whereas 3 vaccinees responded to the foreign antigen: 1 developed an 80-fold rise in serum anti-sporozoite antibody, another had a 4-fold rise in antibody to a recombinant portion of CSP (residues 309-345), while a third vaccinee developed CSP-specific CD8(+) cytotoxic T lymphocyte activity. This is the first report of attenuated S. typhi eliciting a human serologic or a cytotoxic T lymphocyte response to a foreign protein. Improved foreign gene expression should enhance immunogenicity.
引用
收藏
页码:927 / 931
页数:5
相关论文
共 37 条
  • [1] CLINICAL ACCEPTABILITY AND IMMUNOGENICITY OF CVD 908 SALMONELLA-TYPHI VACCINE STRAIN
    TACKET, CO
    HONE, DM
    LOSONSKY, GA
    GUERS, L
    EDELMAN, R
    LEVINE, MM
    VACCINE, 1992, 10 (07) : 443 - 446
  • [2] EXPRESSION OF A STABLE TETANUS TOXIN FRAGMENT C-DIPHTHERIA TOXIN PROTEIN FUSION IN THE ATTENUATED SALMONELLA-TYPHI CVD-908 VACCINE STRAIN
    GALEN, JE
    GOMEZDUARTE, OG
    CHATFIELD, S
    EIDELS, L
    RAPPUOLI, R
    LEVINE, MM
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 257 - 257
  • [3] STRAIN VARIATION IN THE CIRCUMSPOROZOITE PROTEIN GENE OF PLASMODIUM-FALCIPARUM
    LOCKYER, MJ
    SCHWARZ, RT
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 165 - 165
  • [4] STRAIN VARIATION IN THE CIRCUMSPOROZOITE PROTEIN GENE OF PLASMODIUM-FALCIPARUM
    LOCKYER, MJ
    SCHWARZ, RT
    MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1987, 22 (01) : 101 - 108
  • [5] Immunogenicity of a Salmonella typhi CVD 908 candidate vaccine strain expressing the major surface protein gp63 of Leishmania mexicana mexicana
    González, CR
    Noriega, FR
    Huerta, S
    Santiago, A
    Vega, M
    Paniagua, J
    Ortiz-Navarrete, V
    Isibasi, A
    Levine, MM
    VACCINE, 1998, 16 (9-10) : 1043 - 1052
  • [6] EXPRESSION OF FRAGMENT C OF TETANUS TOXIN FUSED TO A CARBOXYL-TERMINAL FRAGMENT OF DIPHTHERIA-TOXIN IN SALMONELLA-TYPHI CVD-908 VACCINE STRAIN
    GOMEZDUARTE, OG
    GALEN, J
    CHATFIELD, SN
    RAPPUOLI, R
    EIDELS, L
    LEVINE, MM
    VACCINE, 1995, 13 (16) : 1596 - 1602
  • [7] EXPRESSION OF BORDETELLA-PERTUSSIS ANTIGENS IN THE SALMONELLA-TYPHI LIVE ORAL VACCINE STRAIN CVD908
    BARRY, EM
    GOMEZDUARTE, O
    CHATFIELD, S
    RAPPUOLI, R
    GALEN, JE
    LEVINE, MM
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 255 - 255
  • [8] SAFETY AND IMMUNOGENICITY IN VOLUNTEERS OF A RECOMBINANT PLASMODIUM-FALCIPARUM CIRCUMSPOROZOITE PROTEIN MALARIA VACCINE PRODUCED IN LEPIDOPTERAN CELLS
    HERRINGTON, DA
    LOSONSKY, GA
    SMITH, G
    VOLVOVITZ, F
    COCHRAN, M
    JACKSON, K
    HOFFMAN, SL
    GORDON, DM
    LEVINE, MM
    EDELMAN, R
    VACCINE, 1992, 10 (12) : 841 - 846
  • [9] Construction of a tetR-integrated Salmonella enterica serovar Typhi CVD908 strain that tightly controls expression of the major merozoite surface protein of Plasmodium falciparum for applications in human vaccine production
    Qian, F
    Pan, WQ
    INFECTION AND IMMUNITY, 2002, 70 (04) : 2029 - 2038
  • [10] SAFETY, IMMUNOGENICITY AND LIMITED EFFICACY STUDY OF A RECOMBINANT PLASMODIUM-FALCIPARUM CIRCUMSPOROZOITE VACCINE IN THAI SOLDIERS
    BROWN, AE
    SINGHARAJ, P
    WEBSTER, HK
    PIPITHKUL, J
    GORDON, DM
    BOSLEGO, JW
    KRINCHAI, K
    SUARCHAWARATANA, P
    WONGSRICHANALAI, C
    BALLOU, WR
    PERMPANICH, B
    KAIN, KC
    HOLLINGDALE, MR
    WITTES, J
    QUE, JU
    GROSS, M
    CRYZ, SJ
    SADOFF, JC
    VACCINE, 1994, 12 (02) : 102 - 108